Stem cell policy in the Obama age: UK and US perspectives

Regenerative Medicine

Volumn 6, Issue 1, 2011, Pages 125-132

  Matthews, Kirstin R W ^a   Rowland, Maude L ^a  

^a RICE UNIVERSITY   (United States)

Author keywords

policy; regulation; stem cell; United Kingdom; United States

Indexed keywords

ARTICLE; EMBRYONIC STEM CELL; FERTILIZATION IN VITRO; FUNDING; GOVERNMENT REGULATION; HEALTH CARE POLICY; HUMAN; HUMAN CLONING; LICENSING; MEDICAL ETHICS; MEDICAL INFORMATION; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; POLITICAL SYSTEM; PRIORITY JOURNAL; PUBLIC OPINION; STEM CELL TRANSPLANTATION; UNITED KINGDOM; UNITED STATES;

ANIMALS; ETHICS, MEDICAL; GOVERNMENT REGULATION; GREAT BRITAIN; GUIDELINES AS TOPIC; HUMANS; PUBLIC OPINION; PUBLIC POLICY; STEM CELL RESEARCH; STEM CELLS; UNITED STATES;

EID: 78650668348     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.10.92     Document Type: Article

References (19)

1. Salter B, Harvey O: Stem cell innovation in the USA: the benefits of the minimal state. Regen. Med. 3(4), 597-610 (2008).
2. Warnock M: Report of the committee of inquiry into human fertilisation and embryology. Stationary Office Books UK (1984).
3. Cressey D: UK embryo agency faces the axe. Nature 466, 674 (2010).
4. Cressey D: Quango bonfire kindles advice fears. Nature 467, 895-896 (2010).
5. National Bioethics Advisory Commission: Cloning Human Beings: Report and recommendations of the National Bioethics Advisory Commission. Rockville, MD, USA (1997).
6. National Bioethics Advisory Commission: Ethical Issues in Human Embryonic Stem Cell Research, Volume I, Report and recommendations of the National Bioethics Advisory Commission. Rockville, MD, USA (1998).
7. Harris G: Stem cell financing ban ends, for now. NY Times, 9 September (2010).
8. Levine AD: Research policy and the mobility of US stem cell scientists. Nat. Biotechnol. 24(7), 865-866 (2006).
9. Winston RML: Does government regulation inhibit embryonic stem cell research and can it be effective? Cell Stem Cell 1(1), 27-34 (2007).
10. Noll R: Designing an effective programme of state-sponsored human embryonic stem cell research. Berkeley Technol. Law J. 21(3), 1143-1174 (2006).
11. National Academies: Guidelines for Human Embryonic Stem Cell Research. National Academy Press, Washington DC, USA (2005).
12. Nolan JM, Samad EU, Martins SAR, Brozak SG: The Bankers: US firms could be left behind. Nature 467, 1032-1033 (2010).
13. Owen-Smith J, McCormick J: An international gap in human ES cell research. Nat. Biotechnol. 24(4), 391-392 (2006).
14. Levine AD: Identifying under-and overperforming countries in research related to human embryonic stem cells. Cell Stem Cell 2, 521-524 (2008).
15. Levine AD: Trends in the geographic distribution of human embryonic stem-cell research. Politics Life Sci. 23(2), 40-45 (2005).
16. Pollack A: FDA approves a stem cell trial. NY Times, 23 January (2009).
17. Caulfield T, Zarzeczny A, McCormick J et al.: The stem cell research environment: a patchwork of patchworks. Stem Rev. Rep. 5(2), 82-88 (2009).
18. Downey R, Geransar R: Stem cell research, publics, and stakeholder views. Health Law Rev. 16(2), 70-85 (2008).
19. Gottweis H, Prainsack B: Emotion in political discourse: contrasting approaches to stem cell governance in the USA, UK, Israel, and Germany. Regen. Med. 1(6), 823-829 (2006).